An aerobic gram-negative bacterium was isolated from the blood and sputum of an 84-year-old, chair-bound nursing home resident with acute bacteremic pneumonia. Although the phenotypic characteristics suggested that the bacterium could be Burkholderia pseudomallei, the Vitek 1 system (GNI؉), which can successfully identify 99% of B. pseudomallei strains, showed that the bacterium was "unidentified." Immunoglobulin G against the lipopolysaccharide (LPS) of B. pseudomallei, as detected by an LPS-based enzyme-linked immunosorbent assay with 95% sensitivity, was negative in both the acute-phase and convalescent-phase sera.
mallei (11) . However, the Vitek 1 system (GNIϩ) (bioMerieux Vitek), which can successfully identify 99% of B. pseudomallei strains (9) , showed that it was "unidentified" in three separate experiments ( Table 1 ). The bacterium was sensitive to ceftazidime, amoxicillin-clavulanate, and imipenem but resistant to cotrimoxazole, gentamicin, and amikacin. A Gram smear of the sputum showed numerous polymorphs, and a bacterium with the same biochemical profile was also recovered from the sputum culture. Amoxicillin-clavulanate was discontinued, and intravenous ceftazidime was commenced. Immunoglobulin G (IgG) antibodies against the lipopolysaccharide (LPS) of B. pseudomallei, determined using an in-house developed enzyme-linked immunosorbent assay (ELISA) based on a published protocol (12) , was negative for both the acute-phase serum and the convalescent-phase serum obtained 2 weeks after admission.
Sequencing of the 16S rRNA genes of the isolates recovered from blood and sputum, using our published protocols (14, 15) and LPW81 5Ј-TGGCGAACGGGTGAGTAA-3Ј and LPW205 5Ј-CTTGTTACGACTTCACCC-3Ј (Gibco BRL, Rockville, Md.) as the PCR and sequencing primers, showed that they possessed the same nucleotide sequence. There was no base difference between the 16S rRNA gene sequence of the isolate and that of B. pseudomallei (GenBank accession no. AF093059), 12 (0.9%) base differences between the 16S rRNA gene sequence of the isolate and that of Burkholderia thailandensis (GenBank accession no. U91838), 21 (1.6%) base differences between the 16S rRNA gene sequence of the isolate and that of Burkholderia cepacia (GenBank accession no. AB051408), 23 (1.8%) base differences between the 16S rRNA gene sequence of the isolate and that of B. vietnamiensis (GenBank accession no. AF097534), and 57 (4.4%) base differences between the 16S rRNA gene sequence of the isolate and that of Burkholderia fungorum (in the Joint Genome Institute sequencing project) (Fig. 1) .
Sequencing of the groEL genes of the isolates recovered from blood and sputum, using our published protocol (23) as well as LPW374 5Ј-AGAAGACATCATGGCCGT-3Ј and LPW377 5Ј-ATTACATGTCCATGCCCA-3Ј (Gibco BRL, Rockville, Md.), showed that they possessed the same nucleotide sequence. There were 0 to 5 (0 to 0.3%) base differences between the groEL gene sequence of the isolate and those of other B. pseudomallei strains we reported previously (23) , 42 to 44 (2.6 to 2.7%) base differences between the groEL gene sequence of the isolate and those of other B. thailandensis strains that we reported previously (23) , 77 (4.8%) base differences between the groEL gene sequence of the isolate and that of B. cepacia (GenBank accession no. AF104907), 78 (4.8%) base differences between the groEL gene sequence of the isolate and that of B. vietnamiensis (GenBank accession no. AF104908), and 170 (10.5%) base differences between the groEL gene sequence of the isolate and that of B. fungorum (in the Joint Genome Institute sequencing project), indicating that the isolate was a strain of B. pseudomallei (Fig. 2) . A final diagnosis of melioidosis complicating diabetes mellitus and bronchiectasis was made. Ceftazidime was stopped after 2 weeks, and she was discharged with oral amoxicillin-clavulanate for another 20 weeks.
Melioidosis is a serious human disease endemic in Southeast Asia, caused by a nonfermentative gram-negative bacterium, B. pseudomallei. B. pseudomallei is very different from the other nonfermentative gram-negative bacteria in terms of the spectrum of disease that it can cause. Illness can manifest as an acute, subacute, or chronic process. Moreover, the duration of treatment of melioidosis is very different from that of infections caused by other nonfermentative gram-negative bacteria. In melioidosis, prolonged antimicrobial treatment is mandatory, since a short course of antibiotics is associated with high disease relapse rates.
Although it is of crucial importance to make a correct diagnosis of melioidosis, this has always been difficult for both the clinicians and the laboratory scientists. In most clinical microbiology laboratories, this relies on isolation and accurate identification of the bacterium from clinical specimens such as blood, sputum, and pus. In some laboratories, serodiagnosis is also employed to complement bacterial culture. Although a lot of effort has been spent on the search for immunogenic proteins (17, 18) , the most widely used serodiagnostic tests are still assays which detect antibodies against B. pseudomallei LPS (3, 12, 24, 25) . For phenotypic identification of B. pseudomallei, this is often delayed because laboratory personnel are often unfamiliar with the bacterium, which may be overlooked as "Pseudomonas species" (8) . Although it has recently been shown that the Vitek 1 system, a widely used automated bacterial identification system in clinical microbiology laboratories, is one of the best commercially available systems for phenotypic identification of B. pseudomallei (9) , the identification of the remaining strains with ambiguous biochemical profiles has always been difficult.
Despite the success in using 16S rRNA gene sequencing for identifying most bacterial species (14) (15) (16) (19) (20) (21) (22) , there are "blind spots" within some major genera, in which 16S rRNA gene sequences are found not to be discriminative enough for the identification of certain species. In such circumstances, sequences of essential genes other than 16S rRNA, such as groEL, have been shown to be useful for the identification of some species that cannot be discriminated by 16S rRNA gene sequencing (6, 13) . Since the difference between the 16S rRNA gene sequences of B. pseudomallei and that of B. thailandensis is less than 1%, 16S rRNA gene sequencing is not discriminative enough for identifying the two species confidently. Recently we have reported the use of groEL gene sequencing for successful identification of B. pseudomallei and discrimination between B. pseudomallei and B. thailandensis (23) . In this report, we describe the clinical application and show the importance of applying such a technique in identifying a strain of B. pseudomallei with an ambiguous biochemical profile recovered from a patient without antibody response against the LPS of B. pseudomallei. Furthermore, it reinforced our previous observation that groEL gene sequencing is more discriminative than 16S rRNA gene sequencing in the identification of B. pseudomallei.
Proper identification of the bacterium in this study is crucial, since there would be a radical difference in the duration of (5) . In the present case, the clinical picture of community-acquired pneumonia in the setting of diabetes mellitus was compatible with melioidosis. Moreover, the colonial morphology and simple conventional biochemical tests suggested that the isolate could be B. pseudomallei. However, identification of the bacterium using the Vitek 1 system showed it as "unidentified." In a recently published study, it was reported that only one out of 103 B. pseudomallei strains was unidentified with this automated bacterial identification system (9). According to this report, the probability that our isolate is B. pseudomallei is not high. Furthermore, both the acute and convalescent-phase sera obtained from our patient showed negative results in the ELISA, which has been shown to be 95.7% sensitive by a group in Thailand (12) and 95% sensitive by us (unpublished data) for culture-documented melioidosis. This further reduced the likelihood that our patient was suffering from melioidosis. The final diagnosis of melioidosis was confirmed only after 16S rRNA and groEL gene sequencing. The absence of antibody response to the LPS of B. pseudomallei could be due to the antigenic heterogeneity of LPS among B. pseudomallei isolates. Recently it has been reported that out of 739 B. pseudomallei isolates recovered from patients and animals of different geographical regions, the LPS extracted from 711 (96.2%) revealed identical typical ladder patterns, whereas those extracted from 21 (2.8%) and 7 (0.9%) showed atypical or no ladder patterns (1). Furthermore, it was shown that there were no immunological cross-reactivity between typical and atypical LPS, as demonstrated by Western blot assays using sera obtained from melioidosis patients from whom the typical and atypical LPS were obtained (1) . This observation is in line with the 95% sensitivity of the LPS-based ELISA. We speculate that the LPS of the B. pseudomallei isolated from our patient probably possessed the atypical ladder pattern or did not possess any ladder pattern, leading to the apparent negative antibody response. LPS from B. pseudomallei with LPS of other types should be included to improve the sensitivity of LPS-based antibody detection systems.
The source of the B. pseudomallei infection in our patient remains elusive. B. pseudomallei is a natural saprophyte that can be isolated from soil, stagnant streams, rice paddies, and ponds, which have been quoted as the major natural reservoirs of the bacterium (8) . However, our patient, being a nursing home resident and having been chair bound for several years, had no recent contact with these usual sources of B. pseudomallei. Since the incubation period of melioidosis can be more than 20 years (10), one possible cause of the bacteremic pneumonia would be reactivation of a latent focus as a result of poor diabetic control. On the other hand, it is also possible that on July 10, 2017 by guest http://jcm.asm.org/ our patient acquired the infection via contact with a contaminated water supply of the nursing home. It was reported recently that the source of a cluster of melioidosis cases was linked to the community water supply (4) . In this outbreak, typing by pulsed-field gel electrophoresis revealed that the B. pseudomallei strains isolated from six of the nine patients showed restriction digestion patterns identical to that for a strain isolated from the community water supply but not for soil isolates (4) . This is in line with the evidence that B. pseudomallei bacteria, similar to Legionella pneumophila bacteria, have the ability to survive as endosymbionts in free-living amebae (7), and water supply has been quoted as a major reservoir and source of legionellosis (2) . Further studies should be carried out to ascertain the importance of water supplies as reservoirs of B. pseudomallei, which would have important implications for infection control measures that have to be taken. Nucleotide sequence accession number. The 16S rRNA gene and groEL gene sequences of the B. pseudomallei strain in the present study were submitted to GenBank and given accession numbers AY198339 and AY198338, respectively.
